As a heart specialist, Dr. Califf spent many years main medical trials on the Duke College Medical Middle in North Carolina. Most not too long ago, he led medical coverage and technique for Verily, the life sciences arm at Alphabet, the mother or father firm of Google. Throughout the listening to, he emphasised the worth of current information, a lot in sufferers’ digital medical data, to assist reply troublesome questions in regards to the proof for medication and units.
Republicans requested how he would deal with guidelines round medicines to induce abortion, which had been relaxed through the pandemic after years of tight restrictions. Two days after the listening to, the F.D.A. — beneath Dr. Janet Woodcock, the interim commissioner — introduced that it might completely elevate restrictions, permitting sufferers to terminate a being pregnant within the first 10 weeks after a telemedicine go to with medicines taken at house.
Senator Tommy Tuberville, a Republican committee member from Alabama, stated in an announcement that the latest determination knowledgeable his committee vote. “I consider Dr. Califf will proceed to advance this administration’s pro-abortion agenda, and I can not help his nomination,” he stated.
Senator Mike Braun, a Republican from Indiana, additionally stated he opposed the nomination over abortion insurance policies and opioid considerations. “Below his management in 2016, the F.D.A. expanded entry to the harmful chemical abortion drug mifepristone and did not take motion to stem the tide of the opioid disaster ravaging our nation,” he stated in an announcement.
Dr. Califf was beforehand confirmed in a 89-to-4 Senate vote to steer the F.D.A. over the last 12 months of the Obama administration. If confirmed once more, he’ll face key choices on tobacco management as he tries to stability e-cigarettes as a instrument to assist some stop smoking with out creating a brand new era of customers. Scrutiny round accelerated approvals of medicine can be heightened, given the present debate over the company’s approval of the controversial Alzheimer’s drug Aduhelm.
After Senator Sanders denounced Dr. Califf’s ties to pharmaceutical corporations, which embrace consulting charges and inventory possession amounting to as a lot as $8 million, the nominee instructed the Senate panel in mid-December that he would adjust to ethics guidelines set by the F.D.A. and its mother or father company, the Division of Well being and Human Companies.
Senator Hassan of New Hampshire additionally voted in opposition to Dr. Califf’s nomination. She had pressed him in December on the F.D.A.’s failure to replace the labeling of opioid medicines. Dr. Califf stated the company would proceed to evaluate the proof coming in.